Hydreight Technologies Inc. (“Hydreight” or the “Company”)
(TSXV: NURS)(OTCQB: HYDTF)( FSE: SO6), a fast-growing
telehealth platform enabling flexible home healthcare, is pleased
to announce the ongoing expansion of its doctor network. The
Company has successfully increased its network to over 100
physicians spanning across all 50 US states by contracting with an
independent network of affiliated medical practices to facilitate
the delivery of services to patients. These physician partnerships
support screening calls and an increase in consultation requests,
as well as new services and offerings that are on the Hydreight
platform, where compliance and patient-centred care is of utmost
importance.
“Hydreight has become
a leader in mobile medical health, providing an unparalleled
ecosystem that the Company consistently refines and expands upon to
keep up with patient needs and service preferences,” said Shane
Madden, CEO of Hydreight. “The expansion of our doctor network
complements our established network of nurses, business partners
and pharmacies. Delivering exceptional patient care is top priority
and with over 100 physicians across all 50 US states, we are on our
way to achieve our goal of being the nationwide network of mobile
medical clinics.”
Key Highlights:
- Doctor network now includes over
100 physicians across all 50 US states
- Provides increased medical
oversight leading to the highest levels of compliance and customer
care
- Supports the platforms overall
expansion and increase in booking requests, approximately up 195%
since January 2023 in compared to the first 6 months of 2022
- Enables Hydreight to onboard more
white-label clients
- Hydreight’s doctor network will
continue to expand as the Company achieves its growth
initiatives
- Extending the telemedicine hours of
operation
Expanded Doctor Network
With a commitment to both compliance and creating a seamless and
supportive patient/provider experience, the Company will continue
to expand its doctor network. The Company has seen approximately a
195% increase in booking requests since January 2023 in comparison
to the first 6 months of 2022, commensurate with its expansion and
new service offerings. Additionally, through the Company’s
white-label strategy, the doctor network extends its reach to
benefit other franchises and organizations seeking these
services.
Hydreight’s platform continues to expand towards individualized
healthcare offerings and patient specific medications and services
such as NAD (Nicotinamide Adenine Dinucleotide) and Semaglutide
(among others), which are experiencing heightened demand among the
broader public. The Hydreight platform connects patients and
providers, seamlessly integrates compliance and medical oversight
with the convenience and personalized care and one-on-one
interactions.
Nicotinamide Adenine Dinucleotide (“NAD”) is a key coenzyme for
energy metabolism with diverse benefits, including cognitive
enhancement, improved athletic performance, weight management, pain
reduction, anti-aging effects, and more.
Semaglutide, a GLP-1 receptor agonist, aids weight loss and
diabetes management by lowering blood glucose, slowing gastric
emptying, curbing appetite, and has potential applications in heart
health, PCOS, addiction, neurodegenerative diseases, and sleep
apnea.
About Hydreight Technologies Inc.Hydreight
Technologies Inc. (TSXV: NURS)( OTCQB: HYDTF)( FSE: SO6) is a home
healthcare and wellness platform that bridges the gap between
providers and patients and empowers nurses, med spa technicians,
and other licensed healthcare professionals to deliver services on
a flexible schedule or to add mobile services to existing
location-based operations. Hydreight facilitates medical director
oversight, liability insurance, competitively priced prescriptions
via a 503B licensed pharmacy, and more. The platform includes a
built-in, easy-to-use suite of fully integrated tools for
accounting, documentation, sales, inventory, booking, managing
patient data, and more, making it possible to deliver mobile
medicine across 50 states. Learn more at Hydreight.com.
You can download the Hydreight
Wellness App from the Apple App store or Google Play Store , and
prospective service providers can sign up at:
Hydreight.com/start-a-business/.
On behalf of the Board of Directors
Shane MaddenDirector and Chief Executive OfficerHydreight
Technologies Inc.www.hydreight.comTelephone: (480) 790 6886
For further information about
Hydreight, please contact:
Investor
RelationsContact – Alyssa BarryEmail:
ir@hydreight.comTelephone: 1-833-947-5227
Neither TSXV nor its Regulation
Services Provider (as that term is defined in policies of the TSXV)
accepts responsibility for the adequacy or accuracy of this
release.
This press release does not constitute
an offer of securities for sale in the United States. The
securities being offered have not been, nor will they be,
registered under the United States Securities Act of 1933, as
amended, and such securities may not be offered or sold within the
United States absent U.S. registration or an applicable exemption
from U.S. registration requirements.
Cautionary Note Regarding
Forward-Looking Information
This press release contains statements
which constitute “forward-looking information” within the meaning
of applicable securities laws, including statements regarding the
plans, intentions, beliefs and current expectations of the Company
with respect to future business activities and operating
performance. Forward-looking information is often identified by the
words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”,
“anticipate”, “believe”, “estimate”, “expect”, “approximately” or
similar expressions and includes information regarding expectations
for the Company’s growth in 2023.
Investors are cautioned that
forward-looking information is not based on historical facts but
instead reflects the Company’s management’s expectations, estimates
or predictions concerning future results or events based on the
opinions, assumptions and estimates of management considered
reasonable at the date the statements are made. Although the
Company believes that the expectations reflected in such
forward-looking information are reasonable, such information
involves risks and uncertainties, and undue reliance should not be
placed on such information, as unknown or unpredictable factors
could have material adverse effects on future results, performance
or achievements of the Company. Among the key factors that could
cause actual results to differ materially from those projected in
the forward-looking information are the following: the ability to
obtain requisite regulatory and other approvals with respect to the
business operated by the Company and/or the potential impact of the
listing of the Company’s shares on the TSXV on relationships,
including with regulatory bodies, employees, suppliers, customers
and competitors; changes in general economic, business and
political conditions, including changes in the financial markets;
changes in applicable laws; compliance with extensive government
regulation; and the diversion of management time as a result of
being a publicly listed entity. This forward-looking information
may be affected by risks and uncertainties in the business of the
Company and market conditions.
Should one or more of these risks or
uncertainties materialize, or should assumptions underlying the
forward-looking information prove incorrect, actual results may
vary materially from those described herein as intended, planned,
anticipated, believed, estimated or expected. Although the Company
has attempted to identify important risks, uncertainties and
factors which could cause actual results to differ materially,
there may be others that cause results not to be as anticipated,
estimated or intended. The Company does not intend, and does not
assume any obligation, to update this forward-looking information
except as otherwise required by applicable law.
Grafico Azioni Hydreight Technologies (TSXV:NURS)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Hydreight Technologies (TSXV:NURS)
Storico
Da Giu 2023 a Giu 2024